A U.S. project office connected directly to the production team.
Sucotond USA is the Brooklyn sales and project-coordination office for private label functional gummy programs manufactured at Sucotond (Guangzhou) Health Biotechnology Co., Ltd. The office and production facility have different responsibilities, and buyers should be able to verify both.
Two Roles, One ProjectKnow who owns each step
Clear ownership reduces delays and prevents a sales conversation from being mistaken for product-specific approval.
Brooklyn project office
Coordinates initial requirements, commercial communication, quotation, document requests, project status and delivery planning during Eastern Time business hours.
Overseas production facility
Handles formulation development, production feasibility, manufacturing, in-process controls, batch records and the agreed finished-product testing workflow.
From non-confidential brief to commercial batch
1. Define the target
Share the active, serving, gummy base, package, quantity, market and timing.
2. Review feasibility
Identify the open formulation, process, testing and commercial questions.
3. Approve the sample
Translate the reviewed sample into a written commercial specification.
4. Confirm documents
Agree the release test panel, packaging records and project-specific document package.
5. Produce and release
Execute the commercial batch against the approved requirements and agreed controls.
6. Coordinate delivery
Track the handoff, freight assumptions and delivery communication through the U.S. office.
What buyers can verify independently
Factory identity
Match the legal production-facility name and address to the public NSF listing.
Certification scope
Check the issuing body, facility holder, category scope and current document before relying on a badge.
Project evidence
Request the formula-specific specification, sample identity, test plan and applicable batch records.
How Sucotond USA prepares buyer-facing content
These pages are commercial project-coordination materials from a seller, not independent regulator, laboratory, legal adviser or medical publisher. The method below makes that perspective and its evidence limits visible.
Who publishes it
Sucotond USA's Brooklyn project-coordination office publishes the U.S. buyer guides. The Guangzhou facility is responsible for manufacturing work and project-specific technical records. A named personal reviewer is shown only when that person and review actually exist.
How evidence is handled
Use the closest primary source available: FDA or eCFR requirements, NIH datasets, issuer-controlled certification records, public identity records and formula- or batch-specific documents. Page-specific sources support only the statement they address; they do not create product approval or a universal manufacturing result.
Why the page exists
Each page must help a supplement brand complete a procurement, specification, testing, packaging or evidence decision. A page is not justified merely by a keyword variation, competitor URL or desired word count.
Automation and QA
Automation may assist drafting, data processing, code and deterministic QA. Publication gates check canonical URLs, structured data, links, source boundaries, cross-domain overlap and measurable handoffs. Those gates are not human medical, legal, regulatory or laboratory review.
Updates and corrections
The visible date and dateModified value should change only after a substantive page update—not to manufacture freshness. If a source, calculation or responsibility statement needs correction, email info@sucotondusa.com with the page URL and the exact issue.
Commercial perspective: Sucotond USA coordinates projects for its related Guangzhou production facility. Buyers should independently verify identity, scope, issuer status and the exact project evidence before making a supplier or product decision.
Use the right Sucotond site for the right team.
Separate web roles help buyers and search engines distinguish the Brooklyn project office from the Guangzhou manufacturing company. A statement on either site is not a substitute for current, project-specific evidence.
sucotondusa.com
This is the U.S. office website for American buyer inquiries, preliminary project scoping, quotation coordination and document requests.
sucotond.com
This is the Guangzhou company's website. Manufacturing identity, facility qualification and project evidence should still be checked against the issuing source and the applicable commercial specification.
Verify the office and factory as separate entities.
These public profiles help buyers distinguish the Brooklyn project office from the Guangzhou manufacturing entity. They do not replace project-specific qualification or batch evidence.
Sucotond USA company profile
The independent BevNET/Nombase directory profile identifies Sucotond USA and links back to this website.
Manufacturing-company identity
The LinkedIn company page identifies Sucotond (Guangzhou) Health Biotechnology Co., Ltd. and its manufacturing role.
Open the factory company profile →
The official USPTO TSDR record for SUCOTOND NUTRITION separately identifies the same Guangzhou legal entity as the current owner and shows U.S. registration number 7786820.
Open the official USPTO trademark record →
This is trademark-owner identity evidence—not product approval, facility certification or project-performance evidence.
Bring us a product question, not a finished answer.
A short brief with target dose, package, volume and timing is enough for a preliminary non-confidential review.